Top 10 Companies in the (R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

Global (R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) is a chiral amine compound featuring a cyclopropyl group attached to an ethylamine backbone in its R-enantiomeric configuration. This specialty fine chemical serves as a critical building block and chiral intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) where stereochemical precision is essential for therapeutic efficacy and safety.

The market is witnessing steady growth driven by rising demand for enantiopure intermediates in drug discovery and the expanding pipeline of chiral small‑molecule therapeutics globally. Furthermore, increasing adoption of asymmetric synthesis techniques across pharmaceutical manufacturing and growing investments in contract research and manufacturing organizations (CROs and CMOs) continue to support market expansion. Key suppliers operating in this space include specialty chemical manufacturers focused on chiral building blocks and fine chemical intermediates catering to research institutions and pharmaceutical companies worldwide.

(R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) Market – View in Detailed Research Report

🔟 1. Hairui (Huai’an) Chemical Technology Co., Ltd.

Headquarters: Huai’an, China
Key Offering: Pharmaceutical‑grade (R)-1‑Cyclopropyl ethylamine, customized purity specifications, and contract synthesis services.

Hairui has established a dedicated chiral synthesis facility that leverages enzymatic resolution and asymmetric hydrogenation to deliver high‑purity (R)-enantiomers. The company serves major pharmaceutical manufacturers and CROs with large‑scale production runs, ensuring consistent quality and rapid turnaround.

Sustainability Initiatives:

• Implementation of green biocatalysis to reduce solvent usage and waste.
• Use of renewable energy sources in manufacturing plants.
• Partnerships with academia for process optimization and catalyst development.

9️⃣ 2. Capot Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: High‑purity (R)-1‑Cyclopropyl ethylamine, research‑grade intermediates, and small‑batch production.

Capot specializes in scalable asymmetric synthesis, providing both bulk and custom orders. Their production lines are GMP‑certified, catering to stringent pharmaceutical regulations.

Sustainability Initiatives:

• Continuous‑flow synthesis to improve yield and reduce energy consumption.
• Closed‑loop solvent recovery systems.
• Investment in renewable feedstocks for raw materials.

8️⃣ 3. Shanghai Bojing Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research‑grade (R)-1‑Cyclopropyl ethylamine, custom purity levels, and rapid prototyping.

Shanghai Bojing focuses on providing high‑quality chiral intermediates to R&D laboratories and academic institutions, offering flexible batch sizes and rapid delivery.

Sustainability Initiatives:

• Eco‑friendly synthesis routes with low‑toxicity reagents.
• Waste‑minimization programs and recycling of by‑products.
• Collaboration with universities on green chemistry research.

7️⃣ 4. Ningbo Inno Pharmchem Co., Ltd.

Headquarters: Ningbo, China
Key Offering: Pharmaceutical‑grade (R)-1‑Cyclopropyl ethylamine, large‑scale production, and custom formulations.

Inno Pharmchem has built a robust supply chain, offering bulk quantities with strict quality controls to meet the needs of global pharma giants.

Sustainability Initiatives:

• Adoption of solvent‑free synthesis methods.
• Energy‑efficient catalytic processes.
• Corporate social responsibility programs focused on local community development.

6️⃣ 5. Biosynth Carbosynth (Switzerland)

Headquarters: Basel, Switzerland
Key Offering: Custom chiral intermediates, rapid synthesis, and small‑batch production.

Biosynth Carbosynth specializes in rapid, scalable synthesis of chiral building blocks, serving both pharma and agrochemical markets with high purity standards.

Sustainability Initiatives:

• Use of biocatalysts to reduce hazardous reagents.
• Implementation of green chemistry principles in all processes.
• Carbon‑neutral production targets by 2035.

5️⃣ 6. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: Industrial‑grade (R)-1‑Cyclopropyl ethylamine and process scale‑up services.

Finetech focuses on providing cost‑effective production solutions for industrial applications, maintaining a strong emphasis on process engineering and scale‑up.

Sustainability Initiatives:

• Process optimization to reduce raw material consumption.
• Waste treatment and recycling infrastructure.
• Energy‑saving equipment upgrades.

4️⃣ 7. Enamine Ltd. (Ukraine)

Headquarters: Kyiv, Ukraine
Key Offering: Research‑grade chiral intermediates, rapid synthesis, and R&D support.

Enamine provides a wide range of chiral building blocks to the pharmaceutical and agrochemical sectors, with a strong emphasis on supporting early‑stage drug discovery.

Sustainability Initiatives:

• Implementation of green synthetic routes.
• Use of renewable feedstocks where possible.
• Collaboration with academic institutions on sustainability projects.

3️⃣ 8. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity (R)-1‑Cyclopropyl ethylamine, bulk production, and custom purity specifications.

Trustin specializes in delivering large volumes of pharmaceutical‑grade chiral intermediates, supporting global pharma manufacturers with reliable supply and quality.

Sustainability Initiatives:

• Adoption of continuous‑flow processes to reduce waste.
• Energy‑efficient production lines.
• Participation in industry sustainability forums.

2️⃣ 9. Astatech Inc. (United States)

Headquarters: San Diego, United States
Key Offering: Research‑grade and pharmaceutical‑grade (R)-1‑Cyclopropyl ethylamine, rapid prototyping services.

Astatech offers high‑quality chiral intermediates to the US pharma market, emphasizing compliance with FDA regulations and providing flexible production options.

Sustainability Initiatives:

• Use of green solvents and reagents.
• Implementation of waste‑minimization protocols.
• Corporate sustainability reporting aligned with ESG standards.

---

Download FREE Sample Report: (R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) Market – View in Detailed Research Report

---

Get Full Report: (R)-1-Cyclopropyl ethylamine (CAS 6240-96-6) Market – View in Detailed Research Report

---

Outlook

Looking forward, the (R)-1‑Cyclopropyl ethylamine market is poised for robust expansion driven by the continuous growth of chiral drug pipelines, particularly in oncology, CNS, and metabolic disease segments. Technological advancements in continuous‑flow synthesis and biocatalysis are expected to further reduce production costs while maintaining stringent purity standards, opening opportunities for broader adoption in both pharmaceutical and agrochemical applications.

Future Trends

• Adoption of AI‑driven process optimization to accelerate synthesis route discovery.
• Expansion of contract manufacturing partnerships to support rapid drug development cycles.
• Increasing focus on green chemistry and sustainability to meet regulatory and ESG demands.
• Emergence of new therapeutic areas, such as gene‑editing and antibody‑drug conjugates, requiring high‑purity chiral intermediates.